Position in HROW
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$614,581
New position
Shares Held
17,430
first reported quarter
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026COMMERCE BANK holds $13,769,238 across 9 Drug Manufacturers - Specialty & Generic names. HROW ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
54,660 | $6,461,357 | |
| 2 | VTRS |
Viatris Inc
|
153,946 | $2,079,809 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,292 | $1,751,087 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
37,273 | $891,942 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,274 | $755,456 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
12,639 | $653,309 | |
| 7 | HROW |
Harrow, Inc.
This page
|
17,430 | $614,581 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
38,310 | $364,711 |
All Filings in HROW
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $614,581 | 17,430 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||